VP, Clinical Development

About Artiva:

Artiva is clinical-stage, publicly-traded biotechnology company focused on developing natural killer (NK) cell-based therapies for patients suffering from devastating autoimmune diseases and cancers. Artiva’s lead program, AlloNK®, is an allogeneic, off-the-shelf, non-genetically modified NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity effect of monoclonal antibodies to drive B-cell depletion. AlloNK is delivered in the outpatient setting with no required hospitalization.  

AlloNK is currently being evaluated in three ongoing clinical trials for the treatment of B-cell driven autoimmune diseases. This includes two company-sponsored trials, one in systemic lupus erythematosus for patients with or without lupus nephritis, and a basket trial across autoimmune diseases (Rheumatoid Arthritis,  Systemic Sclerosis, Idiopathic Inflammatory Myopathies and Sjögren’s  Disease), as well as an investigator-initiated basket trial in B-cell driven autoimmune diseases. Artiva’s pipeline also includes CAR-NK candidates targeting both solid and hematologic cancers.

Artiva was founded in 2019 as a spin out of GC Cell, formerly GC Lab Cell Corporation, a leading healthcare company in the Republic of Korea, pursuant to a strategic partnership granting Artiva exclusive worldwide rights (excluding Asia, Australia and New Zealand) to GC Cell’s NK cell manufacturing technology and programs. Artiva is headquartered in San Diego, California.

For more information, visit www.artivabio.com.

Job Summary:
​​​​ The Vice President, Clinical Development will provide strategical leadership across Artiva’s pipeline, ensuring regulatory alignment and cross-functional collaboration to advance clinical assets in support of company’s objectives. This role requires an experienced physician-leader with proven success leading Phase 2/3 and registration studies, who brings well-established development best practices and global clinical experience while thriving in a fast-moving biotech environment.

Duties/Responsibilities:

Define and drive the clinical development strategy for assigned programs.

Translate scientific, translational, and clinical data into clear development plans, milestone decisions, and risk-benefit assessments.

Ensure alignment of clinical strategy with regulatory expectations, target product profiles, and long-term portfolio objectives.

Lead the design and oversight and registration-quality clinical trials, including endpoint selection, patient population strategy, and global development considerations.

Provide senior clinical oversight to ensure trials meet registration standards for quality, safety, and data integrity.

Partner with Biometrics and Regulatory Affairs to ensure clinical strategy supports statistical and regulatory requirements.

Provide ongoing medical oversight of clinical trials, including safety monitoring, emerging data review, and protocol amendments.

Partner closely with Clinical Operations on trial feasibility, site strategy, enrollment planning, and CRO oversight.

Review and interpret clinical data to guide program adjustments and development decisions.

Ensure clinical readiness for audits, inspections, and regulatory review.

Represent Clinical Development in health authority interactions.

Provide clinical leadership for briefing documents, responses to regulatory questions, and clinical components of submissions.

Engage with investigators, advisors, and external experts to support development strategy and trial execution.

Collaborate closely with Translational Medicine, Safety/Pharmacovigilance, Regulatory Affairs, Biometrics, and CMC teams.

Provide clinical input into biomarker strategy, safety strategy, and future lifecycle planning.

Requirements:

MD required

Board certification preferred.

15+ years of clinical development experience in biotechnology and/or pharmaceutical organizations.

Proven leadership of late-stage and registration-enabling clinical trials, including global studies.

Direct involvement in regulatory submissions (e.g., NDA, BLA, MAA) and health authority interactions.

Experience working in well-established pharmaceutical development environments and applying those practices in smaller or earlier-stage organizations.

Background in immunology, autoimmune disease, or cell therapy required.

Experience leading programs through key inflection points (e.g., EOP2, pivotal study initiation, registration readiness).

Strong strategic thinking with the ability to integrate clinical, regulatory, and scientific perspectives.

Deep understanding of global clinical development and registration pathways.

Sound clinical judgment and risk-benefit decision-making capability.

Clear and credible communicator with regulators, investigators, executives, and cross-functional teams.

Sets a high standard for clinical excellence, patient safety, and data integrity.

Operates effectively in ambiguity while driving disciplined execution.

Models transparency, collaboration, and patient-centric decision-making

In addition to a great culture, we offer:

· A beautiful facility 

· An entrepreneurial, highly collaborative, and innovative environment

· Comprehensive benefits, including:

Medical, Dental, and Vision

Group Life Insurance

Long Term Disability (LTD)

401(k) Retirement Plan

Employee Assistance Program (EAP)

Flexible Spending Account (FSA)

Paid Time Off (PTO)

Company paid holidays, including the year-end holiday week

Our recognition program, Bonus.ly, is where you can trade in points earned for things you want.

If all this speaks to you, come join us on our journey!

Base Salary: $350,000 - $385,000. Exact compensation may vary based on skills and experience.